| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/14/2008 | CN100387266C Medicinal composition for eyes, it's preparing process and use thereof |
| 05/14/2008 | CN100387263C Medicinal composition for treating hepatopathy, and its preparing mehtod and use |
| 05/14/2008 | CN100387253C Chinese medicinal composition for preventing virus disease |
| 05/14/2008 | CN100387246C Pharmaceutical composition for treating liver disease and its preparation and application |
| 05/14/2008 | CN100387243C Quality control method of ixeris sonchifolia injection |
| 05/14/2008 | CN100387239C Rareearth beteropoly acid salt (blue) group anti-AIDS medicine and preparation process thereof |
| 05/14/2008 | CN100387237C Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B |
| 05/14/2008 | CN100387223C Quassia injection and its preparation method |
| 05/14/2008 | CN100387220C Preparation for eyes and preparing method thereof |
| 05/14/2008 | CN100387160C Cigarette-like smoking substitute for women use |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371809 Pharmacologically active antiviral peptides |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371762 Infections caused by Gram positive and/or negative pathogens |
| 05/13/2008 | US7371757 Fused heterocycles as inhibitors of glutamate racemase(MURI) |
| 05/13/2008 | US7371755 Antiviral agents |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371720 Cationic peptides of the phylloseptin family isolated from the skin secretion of Phyllomedusa hypochondrialis |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371407 the oil is used as a carrying agent for anti-microbial formulations; comprises terbinafine and other antibiotics; for topical application to the skin or mucosal membranes of a mammal |
| 05/13/2008 | US7371394 Antigenic composition of a Pseudomonas aeruginosa protein |
| 05/13/2008 | US7371392 Cd40 ligand adjuvant for respiratory syncytial virus |
| 05/13/2008 | US7371391 Papilloma virus capsomere vaccine formulations and methods of use |
| 05/13/2008 | US7371390 Vaccine of a hepatitis B viral (HBV) antigen and a human papillomavirus (HPV) antigen with an adjuvant which is a preferential stimulator of TH1 cell response such as QS21 (a Quillaja saponaria saponin); free of a herpes simplex viral antigen; vaccine for adolescents e.g. against cervical cancer |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371375 Protein |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371372 Inosine monophosphate dehydrogenase inhibitor and interferon; hepatitis C |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | CA2469343C Combination of cytochome p450 dependent protease inhibitors |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2378490C Antibiotic/antibiotics (or: antibiotic(s)) preparation with retarding active ingredient release |
| 05/13/2008 | CA2360833C Reovirus for the treatment of cellular proliferative disorders |
| 05/13/2008 | CA2324953C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 05/13/2008 | CA2322847C Steroid derived antibiotics |
| 05/13/2008 | CA2293470C Benzimidazole derivatives |
| 05/13/2008 | CA2283326C An aqueous metal bicarbonate solution and method of use |
| 05/13/2008 | CA2259780C Alcohol based anti-microbial compositions with cosmetic appearance |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2250919C Photopheresis treatment of leukocytes |
| 05/13/2008 | CA2183435C Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
| 05/13/2008 | CA2139655C Deletion mutants as vaccines for cholera |
| 05/08/2008 | WO2008054639A2 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 05/08/2008 | WO2008054250A1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent |
| 05/08/2008 | WO2008054238A1 Biologically active preparation (variants) and a method for the production thereof (variants) |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053764A1 Anti-prion active compound, anti-prion active agent, and method for inhibition of the production of abnormal prion protein |
| 05/08/2008 | WO2008053219A2 Composition for the treatment of gastrointestinal diseases |
| 05/08/2008 | WO2008052912A1 Antimicrobially active composition having a content of bispyridinium alkane (octenidine dihydrochloride) |
| 05/08/2008 | WO2008052323A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 05/08/2008 | WO2008039359A3 Bicyclic pyrimidine kinase inhibitors |
| 05/08/2008 | WO2008033105A8 Hemagglutinin antibody and uses thereof |
| 05/08/2008 | WO2008007153A3 Antiviral compounds |
| 05/08/2008 | WO2007138116A3 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 05/08/2008 | WO2007098033A3 Feedback prodrug |
| 05/08/2008 | WO2007072216A3 Kit and composition of imidazole with enhanced bioavailability |
| 05/08/2008 | WO2007039749A3 Antibacterial pyrrols |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108704 Hydroalcoholic compositions thickened using polymers |
| 05/08/2008 | US20080108685 Novel Use for Alpha Sympathomimetics Having a 2-Imidazoline Structure |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108674 Comprising a micellular complex consisting of a cationic excipient, an anionic dye and a cationic antiseptic |
| 05/08/2008 | US20080108652 Acute/chronic inflammatory disease of peripheral organs and central nervous system (CNS) |
| 05/08/2008 | US20080108651 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
| 05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
| 05/08/2008 | US20080108646 9-fluoro-6,7,-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid; optically pure isomers of Nadifloxacin; bactericide; systemic or topical Gram-positive, Gram-negative bacterial, mycobacterial and nosocomlal pathogen infections |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108617 Modulators of pharmacokinetic properties of therapeutics |
| 05/08/2008 | US20080108610 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae) |
| 05/08/2008 | US20080108586 Combination therapy for human immunodeficiency virus infection |
| 05/08/2008 | US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080108139 Composition of matter comprising primary nucleic acid component |
| 05/08/2008 | US20080108107 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 05/08/2008 | US20080107752 Detoxified venom and constituent neurotoxins; alpha-bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin, alpha-cobrotoxin, alpha-conotoxins, alpha-dendrotoxin, erabutoxin; protect from viral, bacterial, parasitic infections; administer orally, subcutaneously, intramuscularly, intravenously |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107707 Polymerizable antimicrobial composition |
| 05/08/2008 | US20080107691 Vibrio cholerae strains vcusm1 and vcusm4, method of producing same, and vaccine derivatives thereof |
| 05/08/2008 | US20080107686 Such as granulocyte-macrophage colony stimulating factor; cytokines; kits; capsules |
| 05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/08/2008 | US20080107672 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
| 05/08/2008 | US20080107671 Vaccine comprising yeast vehicle and hepatitis c viral protease fusion for use in prevention and treatment of viral disease |
| 05/08/2008 | US20080107670 Antigenic peptides based on gag protein conserved regions for use in treatment and prevention of viral infection; viricides |
| 05/08/2008 | US20080107669 Antigenic peptides based on gag protein conserved regions for use in treatment and prevention of viral infection; viricides |
| 05/08/2008 | US20080107634 Using mix comprising bifidobacterium and lactobacillus as tool in treatment of gastrointestinal and influenzal disorders |
| 05/08/2008 | US20080107628 Phosphonate inhibitors of HCV |
| 05/08/2008 | US20080107625 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107624 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107623 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |